Cargando…
Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
Histone H3 lysine 9 dimethylation (H3K9me2) is mainly regulated by the histone lysine methyltransferase G9a and is associated with the repression of transcription. However, both the role of G9a and the significance of H3K9me2 in hepatocellular carcinoma (HCC) cells remain unclear. In this study, we...
Autores principales: | Yokoyama, Masayuki, Chiba, Tetsuhiro, Zen, Yoh, Oshima, Motohiko, Kusakabe, Yuko, Noguchi, Yoshiko, Yuki, Kaori, Koide, Shuhei, Tara, Shiro, Saraya, Atsunori, Aoyama, Kazumasa, Mimura, Naoya, Miyagi, Satoru, Inoue, Masanori, Wakamatsu, Toru, Saito, Tomoko, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Tawada, Akinobu, Otsuka, Masayuki, Miyazaki, Masaru, Yokosuka, Osamu, Iwama, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400586/ https://www.ncbi.nlm.nih.gov/pubmed/28423509 http://dx.doi.org/10.18632/oncotarget.15528 |
Ejemplares similares
-
Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
por: Chiba, Tetsuhiro, et al.
Publicado: (2014) -
Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013) -
Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells
por: Kanayama, Kengo, et al.
Publicado: (2019) -
Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016) -
Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma
por: Wakamatsu, Toru, et al.
Publicado: (2017)